Drug Type ASO |
Synonyms- |
Target |
Action modulators |
Mechanism LMNB1 modulators(lamin B1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukodystrophy, Demyelinating, Adult-Onset, Autosomal Dominant | Phase 2 | United States | 01 Feb 2025 |